Controlled Substances: Best Practices for Prescribers
- In 2016, over 50 million U.S. adults experienced chronic pain
- Chronic pain affects an estimated 30 to 40% of the U.S. population with as many as 8% of U.S. adults experiencing high-impact chronic pain
- 90% of all diseases have some pain component
- Up to 35 to 50% of patients with pain also suffer from depression
- 50 million Americans take some kind of chronic pain medication
- 25% of the decline in U.S. labor force participation is due to opioid overprescribing In 2016, over 50 million U.S. adults experienced chronic pain
- Chronic pain affects an estimated 30 to 40% of the U.S. population with as many as 8% of U.S. adults experiencing high-impact chronic pain
- 90% of all diseases have some pain component
- Up to 35 to 50% of patients with pain also suffer from depression
- 50 million Americans take some kind of chronic pain medication
- 25% of the decline in U.S. labor force participation is due to opioid overprescribing
- In 2016, over 50 million U.S. adults experienced chronic pain
- Chronic pain affects an estimated 30 to 40% of the U.S. population with as many as 8% of U.S. adults experiencing high-impact chronic pain
- 90% of all diseases have some pain component
- Up to 35 to 50% of patients with pain also suffer from depression
- 50 million Americans take some kind of chronic pain medication
- 25% of the decline in U.S. labor force participation is due to opioid overprescribing
Learning Objectives
- Discuss the CDC guidelines for appropriate use of opioid pain medications
- Describe the red flags that may indicate a potential opioid abuse issue
- Review the importance of KASPER reports
- Evaluate the need for opioid stewardship
Additional Information
Presenter: Melinda C. Joyce
Pharm.D., FAPhA, FACHE
Credits: 1.5 KBN contact hours, of which 1.5 may be applied towards pharmacology and the KBN requirement for HB1.
Starting Program Date: September 14, 2020
Ending Program Date: availability is under periodic review for currency. Online registration is currently available until: 9/14/2022
This educational activity offers 1.5 KBN contact hours of CE, in which 1.5 may be applied towards pharmacology and the KBN requirement for HB1. KANPNM is accredited as a provider for the Kentucky Board of Nursing (provider # 1-0018). Expiration Date: December 31, 2023. Participants must complete the program within 30 days of purchase, in addition to your required signature, quiz and evaluation to receive CE credit.
Available Credit
- 1.50 AANP Contact Hours
- 1.50 Pharmacology
- 1.50 AANP Pharmacology Contact Hours
Price
This course is offered through the Kentucky Association of Nurse Practitioners & Nurse-Midwives (KANPM).
To take this course you will be redirected to KANPM's website. You must login or create an account with KANPM in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!
Topics